Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study.
Poo JL, Torre A, Aguilar-Ramírez JR, Cruz M, Mejía-Cuán L, Cerda E, Velázquez A, Patiño A, Ramírez-Castillo C, Cisneros L, Bosques-Padilla F, Hernández L, Gasca F, Flores-Murrieta F, Treviño S, Tapia G, Armendariz-Borunda J, Muñoz-Espinosa LE.
Poo JL, et al.
Hepatol Int. 2020 Sep;14(5):817-827. doi: 10.1007/s12072-020-10069-3. Epub 2020 Aug 19.
Hepatol Int. 2020.
PMID: 32813194
Free PMC article.
Clinical Trial.